Digital Marketing Campaign to Highlight Clinical-Stage Cancer Innovation OST-HER2 that activates cellular immunity against ...

Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

In May 2024, IsoPet ® was launched as a standalone division within Vivos Inc., reaffirming the company's commitment to ...

Puma Biotechnology faces challenges but has a solid financial base. Learn why PBYI stock is a "Buy" with potential upside ...

OS Therapies, Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it has entered into ...

Out with the old, in with the new. The end of the year in biopharma is typically marked by pipeline clear outs, and 2024 is ...

Both vibostolimab and favezelimab have had disappointing runs leading up to their termination, sustaining several late-stage ...

Martin Dietrich, MD, PhD, discusses how the FDA-approved combination therapy is transforming care for resectable early-stage ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise ...

Slow-wave sleep plays a crucial role in strengthening memory by enhancing synaptic connections in the brain, with new ...

Background Limited research exists on screening thresholds for low-dose CT in detecting malignant pure ground-glass lung ...